Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity trends 1 and 3 months after second BNT162B2 vaccination among healthcare workers in Israel.
Shachor-Meyouhas Y, Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Weissman A, Mekel M, Hyams G, Horowitz NA, Gepstein V, Netzer I, Saban HC, Petersiel N, Tarabeia J, Halberthal M. Shachor-Meyouhas Y, et al. Among authors: horowitz na. Clin Microbiol Infect. 2022 Mar;28(3):450.e1-450.e4. doi: 10.1016/j.cmi.2021.11.014. Epub 2021 Nov 24. Clin Microbiol Infect. 2022. PMID: 34838782 Free PMC article.
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers.
Hussein K, Dabaja-Younis H, Szwarcwort-Cohen M, Almog R, Leiba R, Weissman A, Mekel M, Hyams G, Horowitz NA, Gepstein V, Cohen Saban H, Tarabeia J, Halberthal M, Shachor-Meyouhas Y. Hussein K, et al. Among authors: horowitz na. Vaccines (Basel). 2022 Oct 18;10(10):1741. doi: 10.3390/vaccines10101741. Vaccines (Basel). 2022. PMID: 36298606 Free PMC article.
Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers.
Shachor-Meyouhas Y, Dabaja-Younis H, Magid A, Leiba R, Szwarcwort-Cohen M, Almog R, Mekel M, Weissman A, Hyams G, Gepstein V, Horowitz NA, Cohen Saban H, Tarabeia J, Halberthal M, Hussein K. Shachor-Meyouhas Y, et al. Among authors: horowitz na. Vaccines (Basel). 2023 Jan 28;11(2):283. doi: 10.3390/vaccines11020283. Vaccines (Basel). 2023. PMID: 36851161 Free PMC article.
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Cohen YC, Magen H, Lavi N, Gatt ME, Chubar E, Horowitz N, Kreiniz N, Tadmor T, Trestman S, Vitkon R, Rouvio O, Shvetz O, Shaulov A, Ziv-Baran T, Avivi I. Cohen YC, et al. Ann Hematol. 2020 Jun;99(6):1273-1281. doi: 10.1007/s00277-020-03985-9. Epub 2020 Mar 20. Ann Hematol. 2020. PMID: 32193630
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin Lymphomas.
Azoulay D, Tapuchi T, Ronen O, Akria L, Cohen HI, Surio C, Chepa SR, Eshel E, Zarfati M, Stemer G, Horowitz NA. Azoulay D, et al. Among authors: horowitz na. Ann Hematol. 2024 May 23. doi: 10.1007/s00277-024-05807-8. Online ahead of print. Ann Hematol. 2024. PMID: 38777843
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Shafat T, et al. Among authors: horowitz na. Cancer Med. 2024 Feb;13(3):e6997. doi: 10.1002/cam4.6997. Cancer Med. 2024. PMID: 38400683 Free PMC article.
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Bairey O, Taliansky A, Glik A, Amiel A, Yust-Katz S, Gurion R, Zektser M, Porges T, Sarid N, Horowitz NA, Shina TT, Lebel E, Cohen A, Geiger KR, Raanani P, Wolach O, Siegal T. Bairey O, et al. Among authors: horowitz na. Cancer. 2023 Dec 15;129(24):3905-3914. doi: 10.1002/cncr.34985. Epub 2023 Aug 12. Cancer. 2023. PMID: 37572086 Clinical Trial.
59 results